{"transactions":[{"id":712035,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2026-07-09T20:12:01.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":6800,"price":5.29,"value":35972.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027."}],"balance_after":6800,"derivative":{"exercise_price":5.29,"expiration_date":"2036-07-06","underlying":"Common Stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001108205-26-000094","document":"wk-form4_1783627918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820526000094/wk-form4_1783627918.xml","form_type":"4"}},{"id":730508,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-23T01:48:08.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":13562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":13562,"derivative":{"exercise_price":31.74,"exercise_date":"2027-06-18","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":13562},"source":{"system":"sec-edgar","filing":"0001104659-26-076567","document":"tm2618519-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000110465926076567/tm2618519-2_4seq1.xml","form_type":"4"}},{"id":1105037,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-20T23:31:33.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":15502,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15502,"derivative":{"exercise_price":24.89,"exercise_date":"2026-06-18","expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":15502},"source":{"system":"sec-edgar","filing":"0001104659-25-061268","document":"tm2518583-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000110465925061268/tm2518583-2_4seq1.xml","form_type":"4"}},{"id":1137781,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2025-05-22T20:13:41.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":14400,"price":3.13,"value":45072.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option grant, as disclosed in Curis Inc.'s 2025 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 28, 2025, contingent upon shareholder approval of Curis's Amendment No. 1 to the Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if Amendment No. 1 to the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 20, 2025, at the 2025 annual meeting of shareholders, Curis's shareholders approved Amendment No. 1 to the Fifth Amended and Restated 2010 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026."}],"balance_after":14400,"derivative":{"exercise_price":3.13,"expiration_date":"2035-01-27","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0001108205-25-000068","document":"wk-form4_1747944814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820525000068/wk-form4_1747944814.xml","form_type":"4"}},{"id":1291024,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2025-01-30T21:03:48.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":1600,"price":3.13,"value":5008.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026."}],"balance_after":1600,"derivative":{"exercise_price":3.13,"expiration_date":"2035-01-27","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001108205-25-000006","document":"wk-form4_1738271021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820525000006/wk-form4_1738271021.xml","form_type":"4"}},{"id":1468163,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T20:53:21.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":19350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest with respect to all of the shares underlying such option on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to the non-employee director's continued service as a director."}],"balance_after":19350,"derivative":{"exercise_price":1.22,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":19350},"source":{"system":"sec-edgar","filing":"0001104659-24-075717","document":"tm2418415-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000110465924075717/tm2418415-1_4seq1.xml","form_type":"4"}},{"id":1504124,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2024-05-23T20:08:22.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":4250,"price":11.62,"value":49385.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025."}],"balance_after":4250,"derivative":{"exercise_price":11.62,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001108205-24-000049","document":"wk-form4_1716494885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820524000049/wk-form4_1716494885.xml","form_type":"4"}},{"id":1509020,"issuer":{"id":4699,"kind":"organization","name":"ArriVent BioPharma, Inc."},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-20T21:30:56.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":29550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest annually in equal installments over three years, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29550,"derivative":{"exercise_price":20.15,"expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":29550},"source":{"system":"sec-edgar","filing":"0001104659-24-063518","document":"tm2414893-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000110465924063518/tm2414893-2_4seq1.xml","form_type":"4"}},{"id":1556385,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-01T22:59:39.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":38700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest over three years in equal monthly installments following April 1, 2024, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date."}],"balance_after":38700,"derivative":{"exercise_price":2.09,"expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":38700},"source":{"system":"sec-edgar","filing":"0001104659-24-042053","document":"tm2410345-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000110465924042053/tm2410345-2_4seq1.xml","form_type":"4"}},{"id":1858839,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:06:46.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant."}],"balance_after":20000,"derivative":{"exercise_price":0.11,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001694665-23-000087","document":"wk-form4_1686600399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000169466523000087/wk-form4_1686600399.xml","form_type":"4"}},{"id":2047771,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2023-01-24T21:15:36.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 23, 2024), subject to the director's continued service with the Company."}],"balance_after":85000,"derivative":{"exercise_price":0.75,"expiration_date":"2033-01-22","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001108205-23-000015","document":"wf-form4_167459490789291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820523000015/wf-form4_167459490789291.xml","form_type":"4"}},{"id":2151279,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-26T20:06:05.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":97063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis commencing on October 23,2022 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders."}],"balance_after":97063,"derivative":{"exercise_price":0.9152,"exercise_date":"2022-10-23","expiration_date":"2032-09-22","underlying":"Common Stock","underlying_shares":97063},"source":{"system":"sec-edgar","filing":"0001437749-22-023055","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000143774922023055/rdgdoc.xml","form_type":"4"}},{"id":2200299,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-29T22:31:06.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":63195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in two equal installments on the first and second anniversaries of the grant date."}],"balance_after":63195,"derivative":{"exercise_price":0.38,"exercise_date":"2023-07-27","expiration_date":"2032-07-26","underlying":"Common Stock","underlying_shares":63195},"source":{"system":"sec-edgar","filing":"0001214659-22-009392","document":"marketforms-56760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000121465922009392/marketforms-56760.xml","form_type":"4"}},{"id":2234202,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T20:44:16.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 9, 2023 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":2.6,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001694665-22-000102","document":"wf-form4_165515304223207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000169466522000102/wf-form4_165515304223207.xml","form_type":"4"}},{"id":2421308,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2022-01-31T22:30:54.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company."}],"balance_after":85000,"derivative":{"exercise_price":3.19,"expiration_date":"2032-01-30","underlying":"Common stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-22-005686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000120919122005686/doc4.xml","form_type":"4"}},{"id":2449465,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-04T23:20:43.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":3538,"price":2.84,"value":10047.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was granted to Mr. Hohneker in lieu of $10,054 of cash compensation otherwise payable to Mr. Hohneker in respect of his services as a director during the fourth quarter of 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was granted to Mr. Hohneker in lieu of $10,054 of cash compensation otherwise payable to Mr. Hohneker in respect of his services as a director during the fourth quarter of 2021."}],"balance_after":3538,"derivative":{"exercise_price":3.72,"exercise_date":"2021-12-31","expiration_date":"2031-12-30","underlying":"Common Stock","underlying_shares":3538},"source":{"system":"sec-edgar","filing":"0001214659-22-000273","document":"marketforms-54944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000121465922000273/marketforms-54944.xml","form_type":"4"}},{"id":2484113,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2021-12-06T13:13:57.000Z","date":"2021-12-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on December 2, 2022, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on December 2, 2025, subject to Dr. Hohneker's continued service on the Company's Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on December 2, 2022, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on December 2, 2025, subject to Dr. Hohneker's continued service on the Company's Board."}],"balance_after":25000,"derivative":{"exercise_price":4.77,"expiration_date":"2031-12-01","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-068030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000120919121068030/doc4.xml","form_type":"4"}},{"id":2538204,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-20T21:58:12.000Z","date":"2021-10-19","kind":"grant","acquired":true,"shares":42866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 ratable quarterly installments commencing March 31, 2022."}],"balance_after":42866,"derivative":{"exercise_price":6.56,"exercise_date":"2022-03-31","expiration_date":"2031-10-18","underlying":"Common Stock","underlying_shares":42866},"source":{"system":"sec-edgar","filing":"0001214659-21-010653","document":"marketforms-54041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000121465921010653/marketforms-54041.xml","form_type":"4"}},{"id":2572006,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-09-13T20:06:54.000Z","date":"2021-09-10","kind":"grant","acquired":true,"shares":22812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis commencing on October 10, 2021 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders."}],"balance_after":22812,"derivative":{"exercise_price":3.97,"exercise_date":"2021-10-10","expiration_date":"2031-09-09","underlying":"Common Stock","underlying_shares":22812},"source":{"system":"sec-edgar","filing":"0001437749-21-022013","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000143774921022013/rdgdoc.xml","form_type":"4"}},{"id":2644873,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true}}],"security":"Stock Options","published_at":"2021-07-02T20:05:39.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":5245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of options to purchase 5,245 shares of the Corporation's common stock, with immediate vesting as to 2,623 shares and 2,622 shares vesting on a monthly basis over two (2) months commencing on the one-month anniversary of the grant date with full vesting, if not fully vested at such time, on the date of the Corporation's next annual meeting of stockholders"}],"balance_after":5245,"derivative":{"exercise_price":5.8,"exercise_date":"2021-07-01","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":5245},"source":{"system":"sec-edgar","filing":"0001437749-21-016341","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000143774921016341/rdgdoc.xml","form_type":"4"}},{"id":2644872,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true}}],"security":"Stock Options","published_at":"2021-07-02T20:05:39.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":15435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase 15,435 shares of the Corporation's common stock, with immediate vesting as to 858 shares and 14,577 shares vesting pro rata over 34 months commencing on the one-month anniversary of the date of grant."}],"balance_after":15435,"derivative":{"exercise_price":5.8,"exercise_date":"2021-07-01","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":15435},"source":{"system":"sec-edgar","filing":"0001437749-21-016341","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000143774921016341/rdgdoc.xml","form_type":"4"}},{"id":2890440,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T22:33:09.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":31380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in thirty-six (36) substantially equal monthly installments over three years following the grant date, subject to continued service on the Board through each such vesting date."}],"balance_after":31380,"derivative":{"exercise_price":16.65,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":31380},"source":{"system":"sec-edgar","filing":"0001694665-21-000025","document":"wf-form4_161195957616497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000169466521000025/wf-form4_161195957616497.xml","form_type":"4"}},{"id":4170241,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:07:42.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":38000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option, which vests annually over three years, beginning January 18, 2017, subject to the director's continued service on the Board, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option, which vests annually over three years, beginning January 18, 2017, subject to the director's continued service on the Board, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."}],"balance_after":0,"derivative":{"exercise_price":4.6,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001209191-17-059627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000120919117059627/doc4.xml","form_type":"4"}},{"id":4485319,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":31280,"kind":"person","name":"Hohneker John","position":1,"cik":"0001695378","reported_name":"Hohneker John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-20T22:58:29.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests annually over three years, beginning on January 18, 2017, subject to the director's continued service on the Board."}],"balance_after":38000,"derivative":{"exercise_price":4.6,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001209191-17-004976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695378/000120919117004976/doc4.xml","form_type":"4"}}]}